Adrenal and Bone Flashcards

(40 cards)

1
Q

Mineralocorticoids

Aldosterone

A

regulates sodium and potassium absorption in collecting tubules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Examples of Glucocorticoids

A

cortisol
prednisone
dexamethasone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Metabolic Effects of Glucocorticoids

A

stim gluconeogenesis
decrease muscle mass
osteoporosis and decreased growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Anti-Inflammatory Effects of Glucocorticoids

A

inhibits PLA2, COX2, IL2, IL3, PAF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Immunosuppressive Effects

A

inhibit cell mediated response

for organ transplants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Examples of Mineralocorticoids

A

aldosterone

fludrocortisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Effects of Mineralocorticoids

A

increases sodium transfer through sodium channels in collecting ducts of kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Excess Mineralocorticoids

A

metabolic alkalosis

increases hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Deficiencies of Adrenocortical Hormones

A

increased ACTH and adrenal hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tx for Addison’s Disease

Chronic Adrenal Insufficiency

A

20-30mg of hydrocortisone QD

supplement with fludrocortisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Tx for Acute Adrenal Insufficiency

A

immediate tx of hydrocortisone

100mg IV every 8 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cushing’s Syndrome

A

from adrenal hyperplasia from tumor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Signs/ Symptoms of Cushing’s Syndrome

A

rounded, trunk obesity, muscle wasting, purple striae, moon face, osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment of Cushing’s Syndrome

A

remove tumor

300mg hydrocortisone QD on day of surgery, reduced over time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ketoconazole MOA

A

inhibits 17a- hydroxylase

blocks synthesis of androgens and cortisol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Use of Ketoconazole

A

fungal infections

rapid reduction of testosterone levels in prostate cancer treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

SE of Ketoconazole

A

hepatotoxicity

menstrual irregularities, gynecomastia, decreased libido, impotence

18
Q

MOA Spironolactone

A

aldosterone receptor blockers

androgen receptor bocker

19
Q

Therapeutic Use of Spironolactone

A

CHF
hyperaldosteronism
female hirsutism

20
Q

SE of Spironolactone

A

hyperkalemia
acidosis
gynecomastia, menstrual irregularities

21
Q

Normal Plasma Levels of Calcium

A

8.5-10.4 mg/dl

22
Q

Phosphate

A

important in intermediary and energy metabolism- making ATP

80% in bone, 15% in soft tissue

23
Q

Vitamin D Synthesis

A

in skin from 7-dehydrocholesterol under UV light

24
Q

Cholecalciferol

A

natural form, obtained from diet

Vit D3

25
Ergocalciferol
plant form, obtained from diet | Vit D2
26
Calcitriol | 1,25- dihydroxyvitamin D
biologically active metabolite of Vit D
27
Parathyroid Hormone
increases Ca and Vit D Ca | decreases calcitonin ca
28
Osteoporosis
low bone density impaired bone architecture poor bone strength
29
RANKL
precursor for osteoclasts | increased with excess glucocorticoids
30
Signs of Osteoporosis
kyphosis | lordosis
31
Postmenopausal Osteoporosis
loss in ovarian hormone production- estrogen loss estrogen increases Ca excretion and decreases Ca absorption lost bone density
32
Alendronate, Risedronate MOA
inhibits bone resorption | decreases osteoclast maturation, number, life span
33
Use of Alendronate, Risedronate
drug of choice for osteoporosis, hypercalcemia
34
SE of Alendronate, Risedronate
esophageal irritation, esophagitis, heartburn | osteonecrosis of jaw
35
Denosumab
inhibits RANKL | treatment of osteoporosis in women and men at high risk of fracture
36
MOA of Denosumab
blocks RANKL from binding its receptor | stopping osteoclastogenesis and increases osteoclast apoptosis
37
SE of Denosumab
infections of bone, muscle, joints
38
MOA of Raloxifene
partial agonist at estrogen receptors
39
Use of Raloxifene
stabilizes and increases bone mineral density | tx and prevention of osteoporosis
40
SE of Raloxifene
hot flushes and increases risk of venous thrombosis